Author Archives: Pluripotency Laboratory

About Pluripotency Laboratory

Dr. Michael Edel completed his Science degree in Anatomy and Human Biology and Physiology with a Masters in a description of pathology associated with human spine degeneration at the University of Western Australia. His PhD thesis focused on mechanisms of neoplastic growth in the field of Pathology at the same University. His high level of scholarship has been recognised with awards including the French/Australia Government fellowship (1998), Anges Watt PhD student Scholarship (1996), the John Nott traveling Fellowship to spend 3 months at Harvard Medical School Boston (2000) and the DURSI fellowship with Dr. Miguel Beato at the CRG (2004). He has specialised during his post-doctoral fellowships on basic cell biology and molecular genetic mechanisms of spinal cord injury, neural stem cells and neural cells in general resulting in a number of high impact publications the past ten years (Cell 2005, Nature Biotechnology 2008, Genes and Development 2010 and Stem Cells and Development 2012). He was project leader on a Carlos III grant entitled: “understanding the role of the cell cycle in self-renewal and pluripotency”, with Dr. Juan Carlos Izpisua Belmonte at the CMRB. In 2011 he was the principle Investigator of a MINECO grant (BFU2011-26596) specialising on new methods to treat spinal cord injury entitled: “Investigation into the role of the cell cycle and apoptosis in human clinical-grade induced pluripotent stem cells and adult stem cells for future application to treat spinal cord injury”. In 2014 he received continued funding from MINECO (BFU2014 54467-P) to derive a clinical grade protocol to safely generate neural cell types to treat spinal cord injury and spinal muscular atrophy in collaboration with Professor Xavier Navarro (UAB) and Dr. Jordi Calderó (University of Lleida). He is currently a group leader, AQU accredited Associate Professor at the University of Barcelona, Faculty of Medicine where he leads a group of six staff/students on multiple projects to investigate new cell based applications to study and treat spinal cord injury as well as other neuron based diseases. His work is supported by Caxia Impulse and has collaborations in Industry to search for new cell based therapy applications.


Welcome to the blog and webpage of Barcelona’s Pluripotency Laboratory.
We are part of the University of Barcelona and we work on induced pluripotent stem cell (iPSC) technology to study neuronal, eye and cardiac diseases at a basic level and for clinical applications. You can find out more about our work by clicking on the pages above or should you require more information, please do not hesitate to contact us.

Dr. Michael Edel
Group Leader
Control of Pluripotency Laboratory
Barcelona, Spain

UB logo

Faculty of Medicine
Department of Biomedicine

Unit of Physiology Science I

Casanova, 143
08036 Barcelona
Tel. & Fax: 93 403 52 78